home

programs

directory by group

resources by island

links

contact us

National HIV/AIDS Clinicians' Consultation Center

U.S. State and Jurisdiction Information

Country and Region Information

 


Specific HIV Medication Information

 

Abacavir (Ziagen)

ADAP (AIDS Drug Assistance Programs)

Adverse Effects of Antiretroviral Therapy (PDF)

AIDS Drug Assistance Programs (ADAP)

Antiretroviral Drug Table 2003 (PDF)

Antiretroviral Therapy in Countries with Low Health Expenditure (PDF)

Antiretroviral Therapy, June 2004 (PDF)

Antiretroviral Therapy, June 2004--Tables and Recommendations (PDF)

Antiretroviral Therapy, New Approached 2003 (PowerPoint)

Antiretroviral Treatment in Resource-Poor Settings:  Clinical Research Priorities (PDF)

Antiretrovirals During Pregnancy in HIV-1-Positive Women in New York City (PDF)

Antiviral Drug Names (PDF)

ARV Drug Monographs (PDF)

Atazanavir (Reyataz) (PDF)

Atovaquone (Mepron) (PDF)

AZT (Retrovir, zidovudine)

Characteristics of Available Antiretroviral Drugs, Sept. 22 2003 (PDF)

Ciprofloxacin (Cipro) (PDF)

Clarithromycin (Biaxin) (PDF)

Clinical Trials

Combivir (AZT and 3TC), Various Languages

Crixivan® (Indinavir)

d4T (Stavudine, Zerit) Information

Dapsone (Avlosulfon) (PDF)

ddC (Zalcitabine, Hivid)

ddI (didanosine, Videx, Videx-EC)

Delavirdine (Rescriptor), Various Languages

Do New HIV Drugs Affect HIV Prevention? (PDF)

Drug Resistance Resources

Efavirenz (Sustiva)

Effect of Highly Active Antiretroviral Therapy on Frequency of Oral Warts (PDF)

Epivir (3TC, lamivudine)

Fluconazole (Diflucan) (PDF)

G-CSF (Granulocyte Colony Stimulating Factor)

Getting the Most Out of Your HIV Regimen

HAART and Host:  Balancing the Response to HIV-1 (PDF)

Hidden Dangers of Incompletely Suppressive Antiretroviral Therapy (PDF)

Highly Active Antiretroviral Therapy (PDF)

Hit Harder Than HAART (PDF)

HIV Prophylaxis After Sexual Assault

HIV Prophylaxis Following Occupational Exposure Guidelines, June 2004 (PDF)

HIV Prophylaxis Following Occupational Exposure Guidelines, June 2004--Tables and Recommendations (PDF)

HIV/AIDS Antiretroviral Medications:  Train the Trainer Curriculum for Nurses in Low Resource Countries (PDF)

HIV/AIDS Antiretroviral Newsletter (WHO)

How HIV Drugs Get Approved (PDF)

Hydroxychloroquine, Hydroxycarbamide, and Didanosine as Economic Treatment for HIV-1 (PDF)

Hydroxyurea

Hydroxyurea (PDF)

Improvement of the Study, Analysis, and Reporting of Adverse Events Associated with Antiretroviral Therapy (PDF)

Indinavir Concentrations and St John's Wort (PDF)

Invirase (saquinavir)

Ketoconazole (Nizoral) (PDF)

Liver Failure After Long-Term Nucleoside Antiretroviral Therapy (PDF)

Long-Term Complications of Antiretroviral Therapy, June 2004 (PDF)

Long-Term Complications of Antiretroviral Therapy, June 2004--Tables and Recommendations (PDF)

Lopinavir (Kaletra)

Nevirapine (Viramune)

New Data Confirm Substantial Variation in Activity of Double Boosted PI Combinations as Optimal Combinations Begin to Emerge (PDF)

Norvir (Ritonavir)

Norvir Patient Information (PDF)

Nystatin (Mycostatin) (PDF)

Once Daily Dosing In HIV (For Allied Healthcare Professionals) (PDF)

Once Daily Dosing In HIV (For Physicians) (PDF)

Pentamidine (PDF)

Planned Interruptions of Anti-HIV Treatment (PDF)

Recent Safety Changes to Product Labeling for Norvir (Ritonavir) (PDF)

Reyataz (PDF)

Salvage Therapy for HIV-1 Infection--The Challenge Grows (PDF)

Septra (Bactrim) (PDF)

Sexual Dysfunction with Protease Inhibitors (PDF)

Side Effects:  Know What to Expect (PDF)

Starting Anti-HIV Medications (Various Languages)

Sustiva (Efavirenz) Information

T-20 (Fuzeon, enfuvirtide), Various Languages

Tenofovir

Tenofovir (Viread), Various Languages

Thalidomide

The Effects of Exercise on the Pharmacokinetics of Drugs (PDF)

The Guide to the Ins and Outs of Antiviral Dosing (PDF)

The Guide to the Ins and Outs of Antiviral Dosing (Spanish) (PDF)

The Hows, Whys, and Wherefores of HIV-1 and Its HAART (PDF)

The Impact of Gender and Pregnancy on Antiretroviral Therapy for HIV:  Pharmacokinetic and Disease (PDF)

Trizivir (abacavir sulfate/lamivudine/zidovudine) Information

Truvada Information

Update on HIV Pharmacotherapy (PowerPoint)

Valganciclovir (Valcyte, valgan) (PDF)

Videx® (Didanosine)

Viracept® (Nelfinavir)

Viramune (Nevirapine)

What Every Internist Should Know about HAART in 2003 (PowerPoint)

What Is A Treatment Interruption?  (Various Languages)

Your Guide to HIV Medications (PDF)

Ziagen (Abacavir)

Back to HIV Related Illnesses/Opportunistic Infections
Back to Non-English Information

 

home

programs

directory by group

resources by island

links

contact us

National HIV/AIDS Clinicians' Consultation Center

U.S. State and Jurisdiction Information

Country and Region Information

 


Comments/questions about this site to: Kevin Patrick
Site and banner created by David Flynn, UH Manoa